Identifying Disparities in the Management of Hip Fractures Within Europe: A Comparison of 3 Health-Care Systems. (4th September 2019)

• Record Type: Journal Article
• Authors: Murray, Cliodhna E.; Fuchs, Andreas; Grünewald, Heide; Godkin, Owen; Südkamp, Norbert P.; Konstantinidis, Lukas
• Is Part Of: Geriatric orthopaedic surgery & rehabilitation. Volume 10(2019)
• Publication Date: 2019-09-04
• Subjects: geriatric trauma -- osteoporosis -- trauma surgery -- systems of care -- fragility fractures -- hip fractures; Older people -- Surgery -- Periodicals; Orthopedic surgery -- Periodicals; Geriatrics -- Rehabilitation -- Periodicals; 617.97
• DOI: 10.1177/2151459319872941
• Languages: English
• ISSNs: 2151-4585

Abstract

Introduction: This study investigates the management of hip fractures in a German maximum care hospital and compares these data to evidence-based standard and practice in 180 hospitals participating in the UK National Hip Fracture Database (NHFD) and 16 hospitals participating in the Irish Hip Fracture Database (IHFD). This is the first study directly comparing the management of hip fractures between 3 separate health-care systems within Europe. Methods: Electronic medical data were collected retrospectively describing the care pathway of elderly patients with a hip fracture admitted to a large trauma unit in the south of Germany "University Hospital Freiburg" (UHF). The audit evaluated demographics, postoperative outcome, and the adherence to the 6 "Blue Book" standards of care. These data were directly compared with the data from the UK NHFD and the IHFD acquired from 180 and 16 hospitals, respectively. Results: At 36 hours, 95.8% of patients had received surgery in UHF, compared to 71.5% in the NHFD and 58% of patients in the IHFD. The rate of in-hospital mortality was 4.7% compared to 7.1% in the NHFD and 5% in the IHFD. The mean average acute length of stay was 13.4 days compared to 16.4 days in the NHFD and 20 days in the IHFD. Reoperation rates are 3.3% compared to 1% in the NHFD and 1.1% in the IHFD; 50.5% of patients were discharged on bone protection medication, compared to 47% in the IHFD and 79.3% in the UK NHFD. Discussion: Despite uniformly acknowledged evidence-based treatment guidelines, the management of hip fractures remains heterogeneous within Europe. Conclusion: These data show that different areas of the hip fracture care pathway in Germany, England, and Ireland, respectively, show room for improvement in light of the growing socioeconomic burden these countries are expected to face.